BIBF 1120/nintedanib: a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.8, 2013-08, pp. : 1081-1088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BIBF 1120 for the treatment of non-small cell lung cancer

By Reck Martin

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 789-794

Informa Healthcare

Access to resources Recommend Favorite

Dacomitinib, a new therapy for the treatment of non-small cell lung cancer

By Brzezniak Christina Carter Corey A Giaccone Giuseppe

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 247-253

Informa Healthcare

Access to resources Recommend Favorite

Non-small cell lung cancer: from targeted therapy to tailored therapy

By Malgieri Simona Feliciano Salvatore Bosso Davide Federico Piera Palmieri Giovannella De Placido Sabino Di Lorenzo Giuseppe Buonerba Carlo

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1817-1819

Informa Healthcare

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Cryoablation Combined with Molecular Target Therapy Improves the Curative Effect in Patients with Advanced Non-small Cell Lung Cancer

By Gu XY Jiang Z Fang W

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1736-1743

Field House Publishing

Access to resources Recommend Favorite